Ryu et al. Development of an in vitro assay system for screening of gp41 inhibitory compounds.Molecules and Cells (1998) vol. 8, No. 6, pp. 717-723.* |
Coligan et al. Induction of the immune system, In Current Protocols in Immunology, John Wiley and Sons, Inc. (1998).* |
Shibo Jiang, Kang Lin and Min Lu, “A Conformation-Specific Monoclonal Antibody Reacting with Fusion-Active gp41 from the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein”, Journal of Virology, Dec. 1998, 10213-10217. |
Shibo Jiang and Asim K. Debnath, “A Salt Bridge Between an N-terminal Coiled Coil of gp41 and an Antiviral Agent Targeted to the gp41 Core Is Important for Anti-HIV-1 Activity”, Biochemical and Biophysical Research Communications, 270, No. 1, p. 153-157 (2000). |
Shibo Jiang and Asim K. Debnath, “Development of HIV Entry Inhibitors Targeted to the Coiled-Coil Regions of gp41”, Biochemical and Biophysical Research Communications, 269, No. 3, p. 641-646 (2000). |
Shibo Jiang, Lin Radigan and Li Zhang, “A Convenient Cell Fusion Assay for Rapid Screening for HIV Entry Inhibitors”, Progress in Biomedical Optics, 1, No. 20, Jan. 26-27, 2000, p. 212-219. |
Shibo Jiang, Kang Lin, Li Zhang, Asim K. Debnath, “A Screening Assay for Antiviral Compounds Targeted to the HIV-1 gp41 Core Structure Using a Conformation-Specific Monoclonal Antibody”, Journal of Virological Methods, 80, p. 85-96 (1999). |
Asim Kumar Debnath, Lin Radigan and Shibo Jiang, “Structure-Based Identification of Small Molecule Antiviral Compounds Targeted to the gp41 Core Structure of the Human Immunodeficiency Virus Type 1”, Journal of Medicinal Chemistry, 42, No. 17, p. 3203-3209 (1999). |
Hong Ji, Wei Shu, F. Temple Burling, Shibo Jiang and Min Lu, “Inhibition of Human Immunodeficiency Virus Type 1 Infectivity by the gp41 Core: Role of a Conserved Hydrophobic Cavity in Membrane Fusion”, Journal of Virology, 73, No. 10, Oct. 1999, p. 8578-8586. |
S. Jiang, N. Strick and A.R. Neurath, “Two Partially Overlapping Antiviral Peptides from the External Portion of HIV Type 1 Glycoprotein 41, Adjoining the Transmembrane Region, Affect the Glycoprotein 41 Fusion Domain”, Aids Research and Human Retroviruses, 11, No. 2, 1995, p. 189-190. |
Shibo Jiang and Kang Lin, “Effect of Amino Acid Replacements, Additions and Deletions of the Antiviral Activity on a Peptide Derived from the HIV-1 GP41 Sequence”, Peptide Research, 8, No. 6, (1995), p. 345-348. |
W. Weissenhorn, A. Dessen, S.C. Harrison, J.J. Skehel & D.C. Wiley, “Atomic Structure of the Ectodomain from HIV-1 gp41”, Nature, 387, May 22, 1997, p. 426-430. |
Jie Cao, Louise Bergeron, Eirik Helseth, Markus Thali, Heinrich Repke and Joseph Sodroski, “Effects of Amino Acid Changes in the Extracellular Domain of the Human Immunodeficiency Virus Type 1 gp41 Envelope Glycoprotein”, Journal of Virology, 67, No. 5, May 1993, p. 2747-2755. |
David C. Chan, Christine T. Chutkowski and Peter S. Kim, “Evidence That a Prominent Cavity in the Coiled Coil of HIV Type 1 gp41 is an Attractive Drug Target”, Proc. Natl. Acad. Sci. USA, 95, pp. 15613-15617, Dec. 1998. |
R.A. Furata, Carl T. Wild, Yongkai Weng and Carol D. Weiss, “Capture of an Early Fusion-Active Conformation of HIV-1 gp41”, Nature Structural Biology, 5, No. 4, Apr. 1998, pp. 276-279. |
Philip L. St. J. Jones, Thomas Korte and Robert Blumenthal, “Conformational Changes in Cell Surface HIV-1 Envelope Glycoproteins Are Triggered by Cooperation between Cell Surface CD4 and Co-receptors”, The Journal of Biological Chemistry, 273, No. 1, Jan. 2, 1998, p. 404-409. |
Andrew C. Good, Todd J.A. Ewing, Daniel A. Gschwend and Irwin D. Kuntz, “New Molecular Shape Descriptors: Application in Database Screening”, Journal of Computer-Aided Molecular Design, 9, (1995) p. 1-12. |
Debra M. Eckert, Vladimir N. Malashkevich, Lily H. Hong, Peter A. Carr and Peter S. Kim, “Inhibiting HIV-1 Entry: Discovery of D-Peptide Inhibitors that Target the gp41 Coiled-Coil Pocket”, Cell, 99, Oct. 1, 1999, p. 103-115. |
Shibo Jiang, Kang Lin, Nathan Strick and A. Robert Neurath, “Inhibition of HIV-1-Infection by a Fusion Domain Binding Peptide from the HIV-1 Envelope Glycoprotein GP41”, Biochemical and Biophysical Research Communications, 195 No. 2, 1993, pp. 533-538. |
Shibo Jiang, Kang Lin, Nathan Strick and A. Robert Neurath, “HIV-1 Inhibition by a Peptide”, Nature, 365, Sept. 9, 1993, p. 113. |
John B. Moore, Bradford A. Jameson, Robin A. Weiss and Quentin J. Sattentan, “The HIV-Cell Fusion Reaction” in Viral Fusion Mechanisms, Edited by Joe Bentz, CRC Press, Boca Raton, FL, 1993, pp. 233-289. |
Yu Feng, Christopher C. Broder, Paul E. Kennedy and Edward A. Berger, “HIV-1 Entry Cofactor: Functional cDNA Cloning a Seven-Transmembrane, G Protein-Coupled Receptor”, Science, 272 May 10, 1996, pp. 872-877. |
William R. Gallaher, Judith M. Ball, Robert F. Garry, Mark C. Griffin and Ronald c. Montelaro, “A General Model for the Transmembrane Proteins of HIV and Other Retroviruses”, Aids Research and Human Retroviruses, 5, No. 4, 1989, pp. 431-440. |
Carl Wild, Terrence Oas, Charlene McDanal, Dani Bolognesi and Thomas Matthews, “A Synthetic Peptide Inhibitor of Human Immunodeficiency Virus Replication: Correlation Between Solution Structure and Viral Inhibition”, Proc. Natl. Acad. Sci. USA, 89, pp. 10537-10541, Nov. 1992. |
Carl T. Wild, Diane C. Shugars, Teresa K. Greenwell, Charlene B. McDanal and Thomas J. Matthews, “Peptides Corresponding to a Predictive α-Helical Domain of Human Immunodeficiency virus Type 1 GP41 are Potent Inhibitors of Virus Infection”, Proc. Natl. Acad. Sci. USA, 91, Oct. 1994, pp. 9770-9774. |
J. Michael Kilby, Sam Hopkins, Thomas M. Venetta, Betty DiMassimo, Gretchen A. Cloud, Jeanette Y. Lee, Leslie Alldredge, Eric Hunter Dani Bolognesi, Thomas Matthews, M. Ross Johnson, Martin A. Nowak, George M. Shaw and Michael S. Saag, “Potent Suppression of HIV-1 Replication in Humans by T-20, a Peptide Inhibitor of gp41-Mediated Virus Entry”, Nature Medicine, 4, No. 11, Nov. 1998, pp. 1302-1307. |
Min Lu, Stephen C. Blacklow and Peter S. Kim, “A Trimeric Structural Domain of the HIV-Transmembrane Glycoprotein”, Nature Structural Biology, No. 12, Dec. 1995, pp. 1075-1082. |
David C. Chan, Deborah Fass, James M. Berger and Peter S. Kim, “Core Structure of gp41 from the HIV Envelope Glycoprotein”, Cell, 89, Apr. 18, 1997, pp. 263-273. |